Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 1
1968 1
1969 1
1970 1
1971 4
1972 1
1973 1
1974 3
1976 1
1978 1
1982 3
1984 1
1986 1
1988 2
1989 7
1990 4
1993 1
1994 4
1997 4
1998 2
1999 1
2000 4
2001 2
2002 2
2003 5
2004 7
2005 2
2006 7
2007 5
2008 2
2011 4
2012 9
2013 12
2014 11
2015 16
2016 19
2017 7
2018 8
2019 13
2020 9
2021 10
2022 20
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Romosozumab and antiresorptive treatment: the importance of treatment sequence.
Cosman F, Kendler DL, Langdahl BL, Leder BZ, Lewiecki EM, Miyauchi A, Rojeski M, McDermott M, Oates MK, Milmont CE, Libanati C, Ferrari S. Cosman F, et al. Among authors: oates mk. Osteoporos Int. 2022 Jun;33(6):1243-1256. doi: 10.1007/s00198-021-06174-0. Epub 2022 Feb 15. Osteoporos Int. 2022. PMID: 35165774 Free PMC article.
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Miller PD, Adachi JD, Albergaria BH, Cheung AM, Chines AA, Gielen E, Langdahl BL, Miyauchi A, Oates M, Reid IR, Santiago NR, Vanderkelen M, Wang Z, Yu Z. Miller PD, et al. Among authors: oates m. J Bone Miner Res. 2022 Aug;37(8):1437-1445. doi: 10.1002/jbmr.4563. Epub 2022 May 20. J Bone Miner Res. 2022. PMID: 35466448 Free PMC article. Clinical Trial.
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.
Robbe P, Ridout KE, Vavoulis DV, Dréau H, Kinnersley B, Denny N, Chubb D, Appleby N, Cutts A, Cornish AJ, Lopez-Pascua L, Clifford R, Burns A, Stamatopoulos B, Cabes M, Alsolami R, Antoniou P, Oates M, Cavalieri D; Genomics England Research Consortium; CLL pilot consortium; Gibson J, Prabhu AV, Schwessinger R, Jennings D, James T, Maheswari U, Duran-Ferrer M, Carninci P, Knight SJL, Månsson R, Hughes J, Davies J, Ross M, Bentley D, Strefford JC, Devereux S, Pettitt AR, Hillmen P, Caulfield MJ, Houlston RS, Martín-Subero JI, Schuh A. Robbe P, et al. Among authors: oates m. Nat Genet. 2022 Nov;54(11):1675-1689. doi: 10.1038/s41588-022-01211-y. Epub 2022 Nov 4. Nat Genet. 2022. PMID: 36333502 Free PMC article.
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
Brown JP, Engelke K, Keaveny TM, Chines A, Chapurlat R, Foldes AJ, Nogues X, Civitelli R, De Villiers T, Massari F, Zerbini CAF, Wang Z, Oates MK, Recknor C, Libanati C. Brown JP, et al. Among authors: oates mk. J Bone Miner Res. 2021 Nov;36(11):2139-2152. doi: 10.1002/jbmr.4409. Epub 2021 Aug 10. J Bone Miner Res. 2021. PMID: 34190361 Free PMC article. Clinical Trial.
Authors' Response.
Bluth EI, Frush DP, Oates ME, Rosenthal SA, Bender C. Bluth EI, et al. Among authors: oates me. J Am Coll Radiol. 2023 Jan;20(1):4-5. doi: 10.1016/j.jacr.2022.12.001. Epub 2022 Dec 9. J Am Coll Radiol. 2023. PMID: 36503173 No abstract available.
Skeletal responses to romosozumab after 12 months of denosumab.
McClung MR, Bolognese MA, Brown JP, Reginster JY, Langdahl BL, Shi Y, Timoshanko J, Libanati C, Chines A, Oates MK. McClung MR, et al. Among authors: oates mk. JBMR Plus. 2021 Jun 3;5(7):e10512. doi: 10.1002/jbm4.10512. eCollection 2021 Jul. JBMR Plus. 2021. PMID: 34258507 Free PMC article.
Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.
Langdahl B, Hofbauer LC, Ferrari S, Wang Z, Fahrleitner-Pammer A, Gielen E, Lakatos P, Czerwinski E, Gimeno EJ, Timoshanko J, Oates M, Libanati C. Langdahl B, et al. Among authors: oates m. Osteoporos Int. 2022 Dec;33(12):2527-2536. doi: 10.1007/s00198-022-06544-2. Epub 2022 Sep 29. Osteoporos Int. 2022. PMID: 36173415 Free PMC article. Clinical Trial.
Summary and conclusions, and abbreviations and acronyms.
Newhauser WD, Williams JP, Noska MA, Borrás C, Holahan EV, Dewji SA, Johnson TE, Hiatt JW, Poston JW, Hertel N, Gress DA, Mills MD, Jordan DW, Sutlief SG, Martin MC, Jackson E, Bluth EI, Frush DP, Oates ME, LaBerge J, Pan HY, Rosenthal SA, Townsend LW, Brady L, Lindegard J, Hall HL, McAndrew-Benavides E, Abelquist E, Anscher MS, Vazquez M, Kronenberg A, Willey JS, Lawrence T, Woloschak GE, Marples B, Wong R, Story M, Howell RW, Hei TK, Tolmachev SY, Auxier JD, Rucker TL, Nilsson M, Sudowe R, Powell BA, Jensen MP. Newhauser WD, et al. Among authors: oates me. J Appl Clin Med Phys. 2022 Dec;23 Suppl 1(Suppl 1):e13846. doi: 10.1002/acm2.13846. J Appl Clin Med Phys. 2022. PMID: 36705249 Free PMC article. No abstract available.
Medical workforce in the United States.
Bluth EI, Frush DP, Oates ME, LaBerge J, Pan HY, Newhauser WD, Rosenthal SA. Bluth EI, et al. Among authors: oates me. J Appl Clin Med Phys. 2022 Dec;23 Suppl 1(Suppl 1):e13799. doi: 10.1002/acm2.13799. Epub 2022 Nov 15. J Appl Clin Med Phys. 2022. PMID: 36382354 Free PMC article. Review.
205 results